-
Hyde Engineering + Consulting Announces Appointment of Chief Executive Officer
prnasia
January 15, 2021
Hyde Engineering + Consulting, Inc. (Hyde) a worldwide partner for solution-based pharmaceutical design and consulting services, announced the appointment of Kerren Bergman as Chief Executive Officer (CEO).
-
Dr David Stamler Appointed CEO
prnasia
January 08, 2021
The Board of Alterity Therapeutics is pleased to announce the appointment of Dr David Stamler to the role of Chief Executive Office effective immediately.
-
Stäubli Group Announces New CEO
americanpharmaceuticalreview
January 06, 2021
Stäubli has announced a new Chief Executive Officer. Gerald Vogt, previously responsible for the global business of the Robotics Division, will take over as CEO from Rolf Strebel on January 1, 2021.
-
Chiesi USA Announces General Manager, Chief Executive Officer Appointment
americanpharmaceuticalreview
December 30, 2020
Chiesi USA, the U.S. affiliate of Chiesi Farmaceutici S.p.A., has announced the appointment of Jon Zwinski as General Manager and Chief Executive Officer of Chiesi USA to advance the company’s global therapeutic efforts. Effective Jan. 1, 2021 ...
-
Samsung Biologics Names John Rim as President and CEO
contractpharma
December 17, 2020
Samsung Biologics has appointed John Rim as its president and chief executive officer. The appointment was made effective immediately and formalized via the company’s board of directors meeting yesterday.
-
STEER appoints Subodh Jindal as CEO
expresspharma
December 17, 2020
He will be responsible for business strategy and plant operations for the engineering business with focused attention to fast-emerging fields of pharma continuous manufacturing solutions, plastic recycling solutions, and the food processing industry.
-
ApiJect Systems Appoints General Counsel & Chief Compliance Officer
contractpharma
December 15, 2020
ApiJect Systems Corp., a global injectable platform technology company that revolutionizes how medicines and vaccines are filled, finished, and delivered, has appointed James A. Garrett as its new general counsel and chief compliance officer.
-
ACG Appoints New CEO
contractpharma
December 09, 2020
Dr. Marcus Michel will be responsible for continuing to drive ACG’s focus on the global pharmaceutical industry.
-
ACG appoints Dr Marcus Michel as new CEO of ACG Engineering
expresspharma
December 08, 2020
He will be responsible for continuing to drive ACG’s focus on the global pharma industry, innovative technologies, business excellence, and institution building.
-
Cytovance Appoints CEO
contractpharma
November 13, 2020
Bin Zhang has been with Cytovance as a member of the Board of Directors since 2018.